Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Corus International is a U.S.-based faith-inspired global development and humanitarian organization, not a biotech or pharmaceutical drug developer. It operates as the parent organization of a family of nonprofit and for-profit entities spanning global public health, international development, impact investing, agricultural livelihoods, and technology-for-development services. Its health work is led primarily through IMA World Health and focuses on health systems strengthening, disease prevention and treatment, maternal and child health, nutrition, immunization, WASH, mental health, and global health security, especially in fragile and low-resource settings. Corus also provides client services and implementation support for governments, businesses, and development partners rather than advancing a therapeutic R&D pipeline. For a biotech analyst, the key point is that Corus is healthcare-related through public health program delivery and health systems work, but it is not a therapeutics company with drug assets or clinical-stage programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Corus International.